5501 ORAL Cetuximab plus platinum-based therapy first-line in recurrent and/or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): Efficacy and safety results of a randomized phase III trial (EXTREME)
| Autor: | Vermorken, J.B., Hitt, R., Geoffrois, L., Erfan, J., Kawecki, A., Zabolotnyy, D., Schueler, A., Knecht, R., Benasso, M., Kienzer, H. |
|---|---|
| Zdroj: | In EJC Supplements 2007 5(4):324-324 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect